BioSpace News Archive

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2020 financial results and operational highlights before open of U.S. markets on Thursday, May 7, 2020. Management will host a conference call and webcast at 8:30 am ET/1:30 pm BST to discuss the company’s financial results and provide a general business updat

GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GW’s Chief Executive Officer, will present a business update at the Bank of America Healthcare Conference 2020 on Tuesday, May 12th, 2020 at 1:40pm EST, which is being held virtually. Live audio webcasts of the presentation a

- SciBase (SCIB) Stockholm, Sweden - announced today that it has received approval from the US Food and Drug Administration (FDA) for Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisense, an AI-based point-of-care system for the non-invasive evaluation of irregular moles remains the only FDA ap

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced the appointment of Elaine V. Jones, Ph.D., as chair of the board of directors. “

Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today provided notice of a change in the location for its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) via the filing of additional proxy materials with the U.S. Securities and Exchange Commission. Due to the public health impact of the coronavirus (COVID-19) pandemic and related government actions, and to support the health and well-being of our employees, stockho

Total Revenue of $12.1 Million Increased 110% Year-over-Year and 46% Sequentially First Quarter 2020 Conference Call Scheduled for May 14

Conference Call and Webcast Scheduled for Thursday, May 7, 2020 at 8:30 AM ET

Veracyte Launches “More About You” Campaign to Educate Patients About Thyroid Cancer Diagnosis

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2020 results after the market closes on Monday, May 11, 2020, to be followed by a conference call at 4:30 p.m. (Eastern Time).